Tuberculosis case fatality rates in high HIV prevalence populations in sub-Saharan Africa

被引:238
作者
Mukadi, YD
Maher, D
Harries, A
机构
[1] Family Hlth Int, HIV AIDS Prevent & Care Dept, Arlington, VA 22201 USA
[2] WHO, Communicable Dis Control Prevent & Eradicat Dept, CH-1211 Geneva, Switzerland
[3] Natl TB Control Programme, Lilongwe, Malawi
关键词
tuberculosis; HIV; mortality; sub-Saharan Africa;
D O I
10.1097/00002030-200101260-00002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Tuberculosis is a leading cause worldwide of morbidity and mortality among HIV-infected people. The HIV era has seen a dramatic increase of the tuberculosis case fatality rate (CFR) in high HIV prevalence populations. Providing care for HIV-infected people must include measures to tackle this high tuberculosis CFR. Aims: To analyse the extent of the increased tuberculosis CFR in high HIV prevalence populations in sub-Saharan Africa, the reasons for this increase and the causes of death, in order to identify possible ways of tackling this problem. Methods: References were obtained by searching the MEDLINE on 'tuberculosis', 'HIV infection', and 'mortality' (MesH or textword). In addition, available data from National Tuberculosis Programme reports were reviewed. Findings: Tuberculosis CFR is closely linked to HIV prevalence. Limited autopsy data suggest that death from HIV-related diseases other than tuberculosis is probably the main reason for the increased CFR in HIV-infected tuberculosis patients. Among HIV-infected tuberculosis patients, the higher tuberculosis CFR in sputum smear-negative and extrapulmonary than in sputum smear-positive tuberculosis cases can also be attributed to misdiagnosis of HIV-related diseases as tuberculosis. The adverse effect of the HIV/AIDS epidemic on general health service performance probably accounts for the higher tuberculosis CFR among HIV-negative tuberculosis patients in high prevalence populations than that in low HIV-prevalence populations. Conclusion: Tackling the problem of the increased tuberculosis CFR in high HIV prevalence populations requires collaboration between tuberculosis control and HIV/ AIDS programmes in implementing measures such as improved health services, tuberculosis and HIV control services, preventive treatment for HIV-related diseases and anti-HIV treatment. (C) 2001 Lippincott Williams & Wilkins.
引用
收藏
页码:143 / 152
页数:10
相关论文
共 56 条
[31]  
Malkin JE, 1997, INT J TUBERC LUNG D, V1, P68
[32]  
MEHER D, 1997, WHOTB97220
[33]   Changing patterns of mortality across Europe in patients infected with HIV-1 [J].
Mocroft, A ;
Vella, S ;
Benfield, TL ;
Chiesi, A ;
Miller, V ;
Gargalianos, P ;
Monforte, AD ;
Yust, I ;
Bruun, JN ;
Phillips, AN ;
Lundgren, JD .
LANCET, 1998, 352 (9142) :1725-1730
[34]  
Moorman J, 1999, INT J TUBERC LUNG D, V3, P786
[35]   Human immunodeficiency virus and the outcome of treatment for new and recurrent pulmonary tuberculosis in African patients [J].
Murray, J ;
Sonnenberg, P ;
Shearer, SC ;
Godfrey-Faussett, P .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) :733-740
[36]   Mycobacterium tuberculosis enhances human immunodeficiency virus-1 replication in the lung [J].
Nakata, K ;
Rom, WN ;
Honda, Y ;
Condos, R ;
Kanegasaki, S ;
Cao, YZ ;
Weiden, M .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1997, 155 (03) :996-1003
[37]   COHORT STUDY OF HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION IN PATIENTS WITH TUBERCULOSIS IN NAIROBI, KENYA - ANALYSIS OF EARLY (6-MONTH) MORTALITY [J].
NUNN, P ;
BRINDLE, R ;
CARPENTER, L ;
ODHIAMBO, J ;
WASUNNA, K ;
NEWNHAM, R ;
GITHUI, W ;
GATHUA, S ;
OMWEGA, M ;
MCADAM, K .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1992, 146 (04) :849-854
[38]  
Onyebujoh PC, 1999, LANCET, V354, P116, DOI 10.1016/S0140-6736(98)10448-8
[39]   Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection [J].
Palella, FJ ;
Delaney, KM ;
Moorman, AC ;
Loveless, MO ;
Fuhrer, J ;
Satten, GA ;
Aschman, DJ ;
Holmberg, SD .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (13) :853-860
[40]   MALABSORPTION OF ANTIMYCOBACTERIAL MEDICATIONS [J].
PELOQUIN, CA ;
MACPHEE, AA ;
BERNING, SE .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (15) :1122-1123